Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Roche Holding AG | 1.21% | $5.16M | CHF272.90B | 26.73% | 73 Outperform | |
| HSBC Holdings | 1.05% | $4.47M | $286.68B | 44.81% | 78 Outperform | |
| ASML Holding | 1.02% | $4.34M | $509.14B | 76.56% | 81 Outperform | |
| Novartis | 0.96% | $4.11M | $302.10B | 38.55% | 80 Outperform | |
| Royal Bank Of Canada | 0.72% | $3.09M | $228.95B | 42.10% | 75 Outperform | |
| Vinci SA | 0.69% | $2.93M | €72.00B | 10.15% | 76 Outperform | |
| Toyota Motor | 0.68% | $2.92M | $290.36B | 15.23% | 81 Outperform | |
| SAFRAN SA | 0.66% | $2.80M | €132.45B | 23.86% | 67 Neutral | |
| GlaxoSmithKline | 0.63% | $2.67M | $109.49B | 36.10% | 77 Outperform | |
| Banco Bilbao | 0.59% | $2.51M | $121.56B | 50.67% | 76 Outperform |